期刊文献+

Roux-en-Y胃转流术对肥胖及其合并疾病疗效的Meta分析 被引量:2

Efficacy of Roux-en-Y Gastric Bypass for Obesity and Its Comorbidities: A Meta-Analysis
原文传递
导出
摘要 目的系统评价Roux-en-Y胃转流术对肥胖及其合并疾病的治疗效果。方法计算机检索Pub Med、EMbase、h e Cochrane Library(2013年第11期)、CBM、CNKI、VIP和Wan Fang Data等数据库,检索时限均截至2013年11月,纳入所有Roux-en-Y胃转流术对肥胖及其合并疾病治疗效果的研究。由2位研究者按照纳入与排除标准筛选文献、提取资料和评价纳入研究的方法学质量后,使用Rev Man 5.3软件进行Meta分析。结果最终纳入25个自身前后对照试验,共2 966例超重或肥胖患者。Meta分析结果显示:与术前比较,Roux-en-Y胃转流术后超重或肥胖患者的体重指数明显下降[MD=–16.40,95%CI(–17.42,–15.38),P<0.000 01],2型糖尿病[RR=0.23,95%CI(0.17,0.31),P<0.000 01]和高血压[RR=0.34,95%CI(0.26,0.43),P<0.000 01]患病率明显降低,空腹血糖、血压和血脂水平均明显改善(P均<0.000 01)。结论 Roux-en-Y胃转流术能明显减轻肥胖患者体重,降低其合并2型糖尿病和心血管疾病的发生率。但因纳入研究在设计上的局限性,本研究结论尚需进一步开展大样本、高质量的随机对照试验加以验证。 Objective To systematically review the efficacy of Roux-en-Y gastric bypass for obesity and its comor- bidities. Methods Such databases as PubMed, EMbase, The Cochrane Library (Issue 11, 2013), CBM, CNKI, VIP and WanFang Data, etc. were electronically searched from inception to November 2013, for including all studies on Roux- en-Y gastric bypass for obesity and its comorbidities. According to inclusion and exclusion criteria, two reviewers inde pendently screened literature, extracted data, and evaluated methodological quality of included studies. And then meta analysis was performed using RevMan 5.3 software. Results A total of 25 before and after self-control studies involving 2 966 cases with overweight or obesity were included. The results of meta-analysis showed that: after Roux-en-Y gastric bypass operation, the patients had significant reduction in BMI (MD= -16.40, 95%CI -17.42 to -15.38, P〈0.000 01), type 2 diabetes mellitus prevalence (RR=0.23, 95%CI 0.17 to 0.31, P〈0.000 01), and hypertension prevalence (RR=0.34, 95%CI 0.26 to 0.43, P〈0.000 01); besides, fasting glucose, blood pressure and serum lipid levels obviously decreased (P〈0.O00 01). Condusion Roux-en-Y gastric bypass for obesity patients is effective in reducing weight loss, type 2 diabetes mellitus incidence and cardiovascular disease incidence. Due to the limitation of the design of the included studies, the conclusion needs to be verified by further conducting high quality randomized controlled trials with large sample-size.
作者 杜润雨 韩萍
出处 《中国循证医学杂志》 CSCD 2014年第11期1343-1350,共8页 Chinese Journal of Evidence-based Medicine
关键词 ROUX-EN-Y胃转流术 肥胖 2型糖尿病 心血管疾病 META分析 Roux-en-Y gastric bypass Obesity Type 2 diabetes meUitus Cardiovascular disease Meta-analysis
  • 相关文献

参考文献32

  • 1World Health Organization. Obesity and overweight EB/OL updated 2013 Mar. Available at: http: //www. cdc. gov/ncidod/EID/htm.
  • 2Sj?str?m L, Gummesson A, Sj?str?m CD, et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol, 2009, 10(7): 653-662.
  • 3Wells G, Shay B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. In: Ottawa, 2012; Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
  • 4Cowan GS Jr, Buffington CK. Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery. World J Surg, 1998, 22(9): 987-992.
  • 5Serra A, Granada ML, Romero R, et al. The effect of bariatric surgery on adipocytokines, renal parameters and other cardiovascular risk factors in severe and very severe obesity: 1-year follow-up. Clin Nutr, 2006, 25(3): 400-408.
  • 6White S, Brooks E, Jurikova L, et al. Long-term outcomes after gastric bypass. Obes Surg, 2005, 15(2): 155-163.
  • 7Bowne WB, Julliard K, Castro AE, et al. Laparoscopic gastric bypass is superior to adjustable gastric band in super morbidly obese patients: a prospective, comparative analysis. Arch Surg, 2006, 141(7): 683-689.
  • 8Cottam D, Atkinson J, Anderson A, et al. A case-controlled matched-pair cohort study of laparoscopic Roux-en-Y gastric bypass and Lap-Band patients in a single US center with three-year follow-up. Obes Surg, 2006, 16(5): 534-540.
  • 9Puzziferri N, Austrheim-Smith IT, Wolfe BM, et al. Three-year follow-up of a prospective randomized trial comparing laparoscopic versus open gastric bypass. Ann Surg, 2006, 243(2): 181-188.
  • 10Alexandrides TK, Skroubis G, Kalfarentzos F. Resolution of diabetes mellitus and metabolic syndrome following roux-en-y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity. Obes Surg, 2007, 17(2): 176-184.

二级参考文献16

  • 1张新国,杨学军,徐红,韩承新,贾元利,武金虎,张冶,高宏凯.胃转流手术治疗2型糖尿病胰岛素抵抗改变的临床研究[J].武警医学,2007,18(4):309-310. 被引量:36
  • 2Zimmet P, Shaw J, Alberti KG. Preventing type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view. Diabet Med, 2003, 20(9): 693-702.
  • 3Yang W, Lu J, Wang J, et al. Prevalence of diabetes among men and women in china. NEngIlMed, 2010, 362(12): 1090-1101.
  • 4Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized con- trolled trial. JAMA, 2008, 299(3): 316-323.
  • 5Buchwald H, Williams SE. Bariatric surgery worldwide 2003. ObesSurg, 2004, 14(9): 1157-1164.
  • 6Cummings DE, Flum DR. Gastrointestinal surgery as a treatment for diabetes. JAMA, 2008, 299(3): 341-343.
  • 7Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. AmJ Med, 2009, 122(3): 248-256.
  • 8Pories WJ, MacDonald KG, Morgan El, et al. Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. AmJ Clin Nutr, 1992, 55(2 Suppl): 582S-585S.
  • 9Higgins J, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration. 2011.
  • 10Yang JT, Li CX, Liu HM, et al, Effects of subtotal gastrectomy and roux-en-Y gastrojejunostomy on the clinical outcome of type 2 dia- betes mellitus.J Surgical Research, 2010, 164(1): 67-71.

共引文献9

同被引文献30

  • 1Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 2014, 384(9945): 766-781.
  • 2Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N EnglJ Med, 2006, 355(8): 763-778.
  • 3Villareal DT, Apovian CM, Kushner RF, et al. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Obes Res, 2005, 13(11): 1849-1863.
  • 4Bacon CG, Mittleman MA, Kawachi I, et al. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med, 2003, 139(3): 161-168.
  • 5Hadi HA, Carr CS, A1 Suwaidi J. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag, 2005, 1(3): 183-198.
  • 6Kolotldn RL, Zunker C, Ostbye T. Sexual functioning and obesity: a review. Obesity (Silver Spring), 2012, 20(12): 2325-2333.
  • 7Hammoud AO, Walker JM, Gibson M, et al. Sleep apnea, reproductive hormones and quality of sexual life in severely obese men. Obesity (Silver Spring), 2011, 19(6): 1118-1123.
  • 8Esposito K, Giugliano D. Obesity, the metabolic syndrome, and sexual dysfunction in men. Clin Pharmacol Ther, 2011, 90(1): 169- 173.
  • 9Kaukua 1, Pekkarinen T, Sane T, et al. Sex hormones and sexual function in obese men losing weight. Obes Res, 2003, 11(6): 689-694.
  • 10Fernandez-Sanchez A, Madrigal-Santillan E, Bautista M, et al. Inflammation, oxidative stress, and obesity. Int J Mol Sci, 2011, 12(5): 3117-3132.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部